Quick answers
- What is Somatuline Depot?
- Somatuline Depot is a brand name of Lanreotide acetate, a prescription medicine. The FDA NDC Directory lists 3 Somatuline Depot products in 3 strengths and forms.
- Who makes Somatuline Depot?
- Ipsen Pharma holds the FDA application for Somatuline Depot (NDA022074, approved August 30, 2007).
- Is there a generic or store brand of Somatuline Depot?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Somatuline Depot product, 7 of them generic. Ask your pharmacist whether one is right for you.
- Has Somatuline Depot been recalled?
- No recall linked to Somatuline Depot products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Somatuline Depot is
Each Somatuline Depot product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lanreotide acetate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lanreotide acetate 120 mg/0.5 mL injection (subcutaneous) | Somatuline Depot | 4 products, 3 companies | DailyMed |
| lanreotide acetate 60 mg/0.2 mL injection (subcutaneous) | Somatuline Depot | 3 products, 2 companies | DailyMed |
| lanreotide acetate 90 mg/0.3 mL injection (subcutaneous) | Somatuline Depot | 3 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lanreotide acetate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022074 | Ipsen Pharma | August 30, 2007 | 3 |
Companies that list Somatuline Depot
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Somatuline Depot products.
- Ipsen Biopharmaceuticals, Inc.3 products
Recalls
No recall linked to Somatuline Depot products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.